P. Craddock

发表

An Adverse Pulmonary Reaction to Cryoprecipitate in a Hemophiliac

J. McCullough, E. Reese, P. Craddock, 2003, Transfusion.

Activation of plasma complement by perfluorocarbon artificial blood: probable mechanism of adverse pulmonary reactions in treated patients and rationale for corticosteroids prophylaxis

G. Vercellotti, H. Jacob, D. Hammerschmidt, 1982 .

Ibuprofen inhibits granulocyte responses to inflammatory mediators

P. Flynn, G. Vercellotti, D. Weisdorf, 1984, Inflammation.

Chronic Myelogenous Leukemia: Development of Blast Crisis With Both Lymphoid and Myeloid Features

T. Lebien, P. Flynn, D. Weisdorf, 1983 .

Complement activation and neutropenia occurring during cardiopulmonary bypass.

D. Stroncek, C. Lammi-Keefe, D. Nicoloff, 1981, The Journal of thoracic and cardiovascular surgery.

Reversal of hemodialysis granulocytopenia and pulmonary leukostasis: A clinical manifestation of selective down-regulation of granulocyte responses to C5adesarg.

K. Skubitz, P. Craddock, 1981, The Journal of clinical investigation.

Rapid in vivo clearance of C5ades arg: a possible protective mechanism against complement-mediated tissue injury.

D. Weisdorf, H. Jacob, D. Hammerschmidt, 1981, The Journal of laboratory and clinical medicine.

Complement-mediated granulocyte activation and down-regulation during hemodialysis

D. Hammerschmidt, P. Craddock, 1984 .

Effect of dialyzer reuse on complement activation and neutropenia in hemodialysis.

D. Stroncek, P. Keshaviah, D. Hammerschmidt, 1984, The Journal of laboratory and clinical medicine.

Complement - Mediated Intravascular Leukostasis and Endothelial Cell Injury

P. Craddock, 1982 .

Acquired granulocyte abnormality during drug allergic reactions: possible role of complement activation

H. Jacob, P. Craddock, T. K. Bowers, 1977 .

Acquired granulocyte abnormality during drug allergic reactions: possible role of complement activation.

H. Jacob, P. Craddock, T. K. Bowers, 1977, Blood.

Complement-mediated granulocyte dysfunction in paroxysmal nocturnal hemoglobinuria.

J. Fehr, H. Jacob, P. Craddock, 1976, Blood.

Complement activation and pulmonary leukotasis during nylon fiber filtration leukapheresis.

A. Dalmasso, R. Kronenberg, H. Jacob, 1978, Blood.

Granulocytes utilize different energy sources for movement and phagocytosis

D. Weisdorf, H. Jacob, P. Craddock, 1982, Inflammation.

Acquired phagocyte dysfunction. A complication of the hypophosphatemia of parenteral hyperalimentation.

Y. Yawata, H. Jacob, S. Silvis, 1974, The New England journal of medicine.

Granulocyte aggregometry: a sensitive technique for the detection of C5a and complement activation.

H. Jacob, D. Hammerschmidt, P. Craddock, 1980, Blood.

Activation of plasma complement by perfluorocarbon artificial blood: probable mechanism of adverse pulmonary reactions in treated patients and rationale for corticosteroids prophylaxis.

G. Vercellotti, H. Jacob, D. Hammerschmidt, 1982, Blood.

Effect of intravascular complement activation on granulocyte adhesiveness and distribution

H. Jacob, P. Craddock, J. O'Flaherty, 1978 .

Glycogenolysis versus glucose transport in human granulocytes: differential activation in phagocytosis and chemotaxis

D. Weisdorf, H. Jacob, P. Craddock, 1982 .

Corticosteroids block binding of chemotactic peptide to its receptor on granulocytes and cause disaggregation of granulocyte aggregates in vitro.

J. August, D. Hammerschmidt, K. Skubitz, 1981, The Journal of clinical investigation.

Corticosteroids inhibit complement-induced granulocyte aggregation. A possible mechanism for their efficacy in shock states.

J. White, H. Jacob, D. Hammerschmidt, 1979, The Journal of clinical investigation.

Granulocyte aggregation as a manifestation of membrane interactions with complement: possible role in leukocyte margination, microvascular occlusion, and endothelial damage.

H. Jacob, D. Hammerschmidt, O. Yamada, 1979, Seminars in hematology.

ASSOCIATION OF COMPLEMENT ACTIVATION AND ELEVATED PLASMA-C5a WITH ADULT RESPIRATORY DISTRESS SYNDROME Pathophysiological Relevance and Possible Prognostic Value

L. J. Weaver, H. Jacob, L. Hudson, 1980, The Lancet.

Complement-induced granulocyte aggregation in vivo.

H. Jacob, D. Hammerschmidt, P. Craddock, 1981, The American journal of pathology.

Effect of staphylococcal α-toxin on neutrophil migration and adhesiveness

P. Peterson, P. Quie, C. Gemmell, 1981, Inflammation.

Deleterious effects of endotoxin on cultured endothelial cells: An in vitro model of vascular injury

M. Boogaerts, H. Jacob, O. Yamada, 1981, Inflammation.

Cholesterol and atheroma lipids activate complement and stimulate granulocytes. A possible mechanism for amplification of ischemic injury in atherosclerotic states.

H. Jacob, C. Greenberg, D. Hammerschmidt, 1981, The Journal of laboratory and clinical medicine.

Potentiation of complement (C5a)-induced granulocyte aggregation by cytochalasin B.

J. White, H. Jacob, P. Craddock, 1978, The Journal of laboratory and clinical medicine.

Atheroma cholesterol activates complement and aggregates granulocytes: possible role in ischemic manifestations of atherosclerosis.

H. Jacob, C. Greenberg, D. Hammerschmidt, 1979, Transactions of the Association of American Physicians.

Pulmonary capillary leukostasis: a complement (C') mediated complication of hemodialysis

J. Fehr, K. Brigham, H. Jacob, 1975 .

Zymosan activation of plasma reduces hypoxic pulmonary vasoconstriction.

E. K. Weir, E. Chesler, P. Craddock, 1983, Respiration physiology.

Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis.

R S Kronenberg, R. Kronenberg, J. Fehr, 1977, The New England journal of medicine.

Complement (C5-a)-induced granulocyte aggregation in vitro. A possible mechanism of complement-mediated leukostasis and leukopenia.

J. White, H. Jacob, D. Hammerschmidt, 1977, The Journal of clinical investigation.

Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damage.

H. Jacob, C. Moldow, P. Craddock, 1978, The Journal of clinical investigation.

Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes.

A. Dalmasso, J. Fehr, K. Brigham, 1977, The Journal of clinical investigation.

Complement-induced granulocyte aggregation: an unsuspected mechanism of disease.

M. J. Moore, H. L. Bleich, H. Jacob, 1980, The New England journal of medicine.

Glycogenolysis versus glucose transport in human granulocytes: differential activation in phagocytosis and chemotaxis.

D. Weisdorf, H. Jacob, P. Craddock, 1982, Blood.

Effect of intravascular complement activation on granulocyte adhesiveness and distribution.

H. Jacob, P. Craddock, J. O'Flaherty, 1978, Blood.

Sudden blindness in acute pancreatitis. Possible role of complement-induced retinal leukoembolization.

G. Weissmann, I. Goldstein, H. Jacob, 1981, Archives of internal medicine.

Digital integration of granulocyte aggregation responses

D. Weisdorf, D. Hammerschmidt, P. Craddock, 1980, Inflammation.

Mechanism of Anti-Complementary Activity of Corticosteroids in Vivo: Possible Relevance in Endotoxin Shock

H. Jacob, P. Craddock, J. O’Flaherty, 1977, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Ibuprofen inhibits granulocyte responses to inflammatory mediators. A proposed mechanism for reduction of experimental myocardial infarct size.

P. Flynn, G. Vercellotti, D. Weisdorf, 1984, Inflammation.

Hyperalimentation hypophosphatemia: hematologic-neurologic dysfunction due to ATP depletion.

Y. Yawata, R. Hebbel, H. Jacob, 1973, Transactions of the Association of American Physicians.

Pulmonary dysfunction in hemodialysis.

K. Brigham, H. Jacob, P. Craddock, 1978, New England Journal of Medicine.

Complement and Granulocyte Activation and Deactivation during Hemodialysis

P. Craddock, 1983 .

Complement, granulocytes, and shock lung.

P. Craddock, 1984, The American journal of emergency medicine.

Corticosteroids inhibit complement-induced granulocyte aggregation. A possible mechanism for their efficacy in shock states.

D. Hammerschmidt, P. Craddock, James G. White, 1979, The Journal of clinical investigation.